These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 24568843

  • 1. Deoxynivalenol: a trigger for intestinal integrity breakdown.
    Akbari P, Braber S, Gremmels H, Koelink PJ, Verheijden KA, Garssen J, Fink-Gremmels J.
    FASEB J; 2014 Jun; 28(6):2414-29. PubMed ID: 24568843
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations.
    Sergent T, Parys M, Garsou S, Pussemier L, Schneider YJ, Larondelle Y.
    Toxicol Lett; 2006 Jul 01; 164(2):167-76. PubMed ID: 16442754
    [Abstract] [Full Text] [Related]

  • 9. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
    Moran GW, O'Neill C, McLaughlin JT.
    Regul Pept; 2012 Oct 10; 178(1-3):95-101. PubMed ID: 22809889
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vulnerability of polarised intestinal porcine epithelial cells to mycotoxin deoxynivalenol depends on the route of application.
    Diesing AK, Nossol C, Dänicke S, Walk N, Post A, Kahlert S, Rothkötter HJ, Kluess J.
    PLoS One; 2011 Feb 25; 6(2):e17472. PubMed ID: 21364771
    [Abstract] [Full Text] [Related]

  • 12. Nontoxic concentrations of OTA aggravate DON-induced intestinal barrier dysfunction in IPEC-J2 cells via activation of NF-κB signaling pathway.
    Ying C, Hong W, Nianhui Z, Chunlei W, Kehe H, Cuiling P.
    Toxicol Lett; 2019 Sep 01; 311():114-124. PubMed ID: 31026484
    [Abstract] [Full Text] [Related]

  • 13. Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism.
    Pinton P, Braicu C, Nougayrede JP, Laffitte J, Taranu I, Oswald IP.
    J Nutr; 2010 Nov 01; 140(11):1956-62. PubMed ID: 20861219
    [Abstract] [Full Text] [Related]

  • 14. Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junction-associated proteins.
    Wang Y, Tong J, Chang B, Wang B, Zhang D, Wang B.
    Mol Med Rep; 2014 Jun 01; 9(6):2352-6. PubMed ID: 24718485
    [Abstract] [Full Text] [Related]

  • 15. The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
    Sayoc-Becerra A, Krishnan M, Fan S, Jimenez J, Hernandez R, Gibson K, Preciado R, Butt G, McCole DF.
    Inflamm Bowel Dis; 2020 Feb 11; 26(3):407-422. PubMed ID: 31751457
    [Abstract] [Full Text] [Related]

  • 16. Assessing Mixture Effects of Cereulide and Deoxynivalenol on Intestinal Barrier Integrity and Uptake in Differentiated Human Caco-2 Cells.
    Beisl J, Varga E, Braun D, Warth B, Ehling-Schulz M, Del Favero G, Marko D.
    Toxins (Basel); 2021 Mar 04; 13(3):. PubMed ID: 33806705
    [Abstract] [Full Text] [Related]

  • 17. Early Activation of MAPK p44/42 Is Partially Involved in DON-Induced Disruption of the Intestinal Barrier Function and Tight Junction Network.
    Springler A, Hessenberger S, Schatzmayr G, Mayer E.
    Toxins (Basel); 2016 Sep 08; 8(9):. PubMed ID: 27618100
    [Abstract] [Full Text] [Related]

  • 18. The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function.
    Dong CX, Zhao W, Solomon C, Rowland KJ, Ackerley C, Robine S, Holzenberger M, Gonska T, Brubaker PL.
    Endocrinology; 2014 Feb 08; 155(2):370-9. PubMed ID: 24265452
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.